Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

0.301
Delayed Data
As of 4:00pm ET
 +0.031 / +11.48%
Today’s Change
0.19
Today|||52-Week Range
1.96
-70.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$31.0M

Company Description

Neuralstem, Inc. is a biopharmaceutical company, which is focused on the research, development and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its patented technology enables the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the potential treatment of central nervous system diseases and conditions. The company was founded by I. Richard Garr, Karl Y. Johe and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Contact Information

Neuralstem, Inc.
20271 Goldenrod Lane
Germantown Maryland 20876
P:(301) 366-4960
Investor Relations:
(301) 366-1481

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Richard J. DalyChairman, President & Chief Executive Officer
Jonathan B. Lloyd JonesChief Financial Officer
Karl Y. JoheChief Scientific Officer
Thomas HazelSenior Vice President-Research
Danielle SpanglerHead-Investor Relations